George Jeffrey P. — SEC Form 4 filings
SEC reporting owner CIK 1796789. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-23 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,592 shares, $49,890 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: purchase of 5,592 shares @ $8.92 ($49,890) in LENZ Therapeutics, Inc., filed 2026-03-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | Director | 4 | 1 leg · 5,592 sh · $49,890 | — | 3 |
| 908 Devices Inc. (MASS) | Director | 3 | — | — | 10 |
| Amneal Pharmaceuticals, Inc. (AMRX) | Director | 4 | — | — | 9 |
Form 4 filings — George Jeffrey P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | LENZ Therapeutics, Inc. (LENZ) | Grant/award (A): 22,100 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | LENZ Therapeutics, Inc. (LENZ) | Purchase (P): 5,592 @ $8.92 | EDGAR |
| 2025-06-13 | 4 | 908 Devices Inc. (MASS) | Option exercise (M): 11,364 · Option exercise (M): 11,364 (derivative) @ $0 · Grant/award (A): 14,083 (derivative) @ $0 · Grant/award (A): 6,516 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | LENZ Therapeutics, Inc. (LENZ) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | 908 Devices Inc. (MASS) | Option exercise (M): 7,777 · Option exercise (M): 7,777 (derivative) @ $0 · Grant/award (A): 11,364 (derivative) @ $0 · Grant/award (A): 15,996 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 40,258 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | LENZ Therapeutics, Inc. (LENZ) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | 908 Devices Inc. (MASS) | Option exercise (M): 508 · Option exercise (M): 508 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796789 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →